| Entry |
|
|---|
| Name |
SARS-CoV-2 S to lectin pathway of complement cascade
|
|---|
| Definition |
S -> (MBL2+MASP1/2) |
|---|
| Expanded |
K24152 -> (4153+(5648,10747)) |
|---|
| Class |
|
|---|
| Type |
Pathogen
|
|---|
| Pathway |
|
|---|
| Disease |
|
|---|
| Gene |
| 4153 | MBL2; mannose binding lectin 2 |
| 5648 | MASP1; mannan binding lectin serine peptidase 1 |
| 10747 | MASP2; mannan binding lectin serine peptidase 2 |
|
|---|
| Perturbant |
| K24152 (S) | S; SARS coronavirus spike glycoprotein |
|
|---|
| Reference |
|
|---|
| Authors |
Noris M, Benigni A, Remuzzi G |
|---|
| Title |
The case of complement activation in COVID-19 multiorgan impact. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Jodele S, Kohl J |
|---|
| Title |
Tackling COVID-19 infection through complement-targeted immunotherapy. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Chauhan AJ, Wiffen LJ, Brown TP |
|---|
| Title |
COVID-19: A collision of complement, coagulation and inflammatory pathways. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
